Skip Nav Destination
Issues
1 November 2016
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
Commentary
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps
Pamela M. Marcus; Nora Pashayan; Timothy R. Church; V. Paul Doria-Rose; Michael K. Gould; Rebecca A. Hubbard; Michael Marrone; Diana L. Miglioretti; Paul D. Pharoah; Paul F. Pinsky; Katherine A. Rendle; Hilary A. Robbins; Megan C. Roberts; Betsy Rolland; Mark Schiffman; Jasmin A. Tiro; Ann G. Zauber; Deborah M. Winn; Muin J. Khoury
Research Articles
Long-term Diet and Biomarker Changes after a Short-term Intervention among Hispanic Breast Cancer Survivors: The ¡Cocinar Para Su Salud! Randomized Controlled Trial
Heather Greenlee; Ann Ogden Gaffney; A. Corina Aycinena; Pam Koch; Isobel Contento; Wahida Karmally; John M. Richardson; Zaixing Shi; Emerson Lim; Wei-Yann Tsai; Regina M. Santella; William S. Blaner; Robin D. Clugston; Serge Cremers; Susan Pollak; Iryna Sirosh; Katherine D. Crew; Matthew Maurer; Kevin Kalinsky; Dawn L. Hershman
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer
Jodie N. Painter; Tracy A. O'Mara; Louise Marquart; Penelope M. Webb; for the AOCS Group; John Attia; Sarah E. Medland; Timothy Cheng; Joe Dennis; Elizabeth G. Holliday; Mark McEvoy; Rodney J. Scott; Shahana Ahmed; Catherine S. Healey; Mitul Shah; Maggie Gorman; Lynn Martin; Shirley V. Hodgson; Matthias W. Beckmann; Arif B. Ekici; Peter A. Fasching; Alexander Hein; Matthias Rübner; Kamila Czene; Hatef Darabi; Per Hall; Jingmei Li; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo B. Runnebaum; Frederic Amant; Daniela Annibali; Jeroen Depreeuw; Diether Lambrechts; Patrick Neven; Julie M. Cunningham; Sean C. Dowdy; Ellen L. Goode; Brooke L. Fridley; Stacey J. Winham; Tormund S. Njølstad; Helga B. Salvesen; Jone Trovik; Henrica M.J. Werner; Katie A. Ashton; Geoffrey Otton; Anthony Proietto; Miriam Mints; Emma Tham; for RENDOCAS; Manjeet K. Bolla; Kyriaki Michailidou; Qin Wang; Jonathan P. Tyrer; John L. Hopper; Julian Peto; Anthony J. Swerdlow; Barbara Burwinkel; Hermann Brenner; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Jenny Chang-Claude; Fergus J. Couch; Graham G. Giles; Vessela N. Kristensen; Angela Cox; Paul D.P. Pharoah; Ian Tomlinson; Alison M. Dunning; Douglas F. Easton; Deborah J. Thompson; for the National Study of Endometrial Cancer Genetics Group (NSECG); Amanda B. Spurdle; for the Australian National Endometrial Cancer Study Group (ANECS)
Letter to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds